Veronica Yolanda Saleh, MD,
Child & Adolescent Psychiatry · Palo Alto
- Medicare standing
- 1 flag on the record
- Listed below.
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
On the public record
- Medicare does not list them as allowed to order and refer
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Saleh’s office at (650) 326-5530 to ask if they take your plan before you enroll.
California Medical Board record
Licence A76667 · Current
Licensed to practise in California · since 2001 · expires 2027-02-28 · University of California, Los Angeles School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Drugs they prescribed that Part D paid
$1,982
Pharmacies billed $1,982 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 90) in 2024. At or below the middle of the specialty; the typical neuropsychiatry clinician is at 0%.
90 generic and 0 brand-name prescriptions · $1,982 in drug cost · 17 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Quetiapine | 17 | $111 | $7 |
| Lorazepam | 12 | $5 | $0 |
Year by year
| 2024 | 90 | None | 0% (0) | 0% | $1,982 |
| 2023 | 82 | None | 0% (0) | None | $2,282 |
| 2022 | 75 | None | 0% (0) | None | $3,655 |
| 2021 | 95 | None | 0% (0) | 0% | $4,055 |
| 2020 | 103 | None | 0% (0) | 0% | $1,973 |
| 2019 | 48 | None | 0% (0) | None | $1,386 |
| 2018 | 40 | None | 0% (0) | 0% | $638 |
| 2015 | 23 | None | 0% (0) | None | $3,495 |
| 2014 | 20 | None | 0% (0) | None | $2,573 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 2 drugs
| Quetiapine | 14 | $98 | $7 |
| Lorazepam | 12 | $10 | $1 |
2022: 2 drugs
| Escitalopram | 13 | $198 | $15 |
| Lorazepam | 13 | $22 | $2 |
2021: 3 drugs
| Quetiapine | 15 | $1,854 | $124 |
| Duloxetine | 24 | $849 | $35 |
| Lorazepam | 11 | $7 | $1 |
2020: 2 drugs
| Quetiapine | 33 | $704 | $21 |
| Duloxetine | 23 | $251 | $11 |
2019: 2 drugs
| Quetiapine | 14 | $502 | $36 |
| Escitalopram | 13 | $148 | $11 |
2015: 1 drug
| Duloxetine | 11 | $500 | $45 |
2014: 1 drug
| Duloxetine | 11 | $1,335 | $121 |
Money from drug and device companies
$22 in 2025
| 2025 | 1 | 1 | None | $22 |
| 2024 | 5 | 7 | None | $709 |
| 2021 | 1 | 2 | None | $40 |
| 2020 | 2 | 2 | None | $50 |
| 2019 | 1 | 1 | None | $16 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Axsome Therapeutics | Auvelity | $22 | 1 payment
|
See the published payment
| Axsome Therapeutics | Meals · 2025-12-03 | Auvelity | $22 |
See earlier years (2024, 2021, 2020, 2019)
2024: $709
| Axsome Therapeutics | Auvelity | $197 | 3 payments
|
| Neurocrine Biosciences | Ingrezza | $140 | 1 payment
|
| Abbvie | Qulipta | $125 | 1 payment
|
| SK Life Science | Xcopri | $125 | 1 payment
|
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Caplyta | $122 | 1 payment
|
2021: $40
| Supernus Pharmaceuticals | Qelbree | $40 | 2 payments
|
2020: $50
| Allergan | Vraylar | $26 | 1 payment
|
| Ironshore Pharmaceuticals | Jornay Pm | $25 | 1 payment
|
2019: $16
| Neurocrine Biosciences | Ingrezza | $16 | 1 payment
|
Professional record
- NPI
- 1275666703
- Licence
- CA A76667California A76667: Current · expires 2027-02-28
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 2084P0804X (2084P0804X)
- Mailing address
- 827 Middlefield Rd, Palo Alto, CA, 94301
- NPI first listed
- 2007-03-13
- NPI last updated
- 2007-07-08
This is when the NPI record was last certified, not a medical board exam.